Browsing: amid

The iconic singer returned to the stage and kicked off a 26-show run in Paris over the weekend, marking six years since her last live performance and four years since she publicly announced she has stiff-person syndrome.

In a bid to solidify its position as a major competitor to Netflix and Disney, Paramount is embroiled in legal challenges surrounding its proposed $1.88 billion bond deal within the Warner Bros. Discovery merger. California’s Attorney General Rob Bonta’s televised remarks have reportedly contradicted his legal stance against Paramount, adding complexities to ongoing negotiations.

Neutrogena’s silence is drawing more scrutiny. Shares of parent company Kenvue Inc. have fallen as the skincare brand faces mounting backlash over Hayden Panettiere’s claim that it dropped her for speaking publicly about postpartum depression. Kenvue stock recently traded near $19.14 as calls to boycott Neutrogena spread following Panettiere’s death at 36 on Aug. 16.